US Stock MarketDetailed Quotes

MRVI Maravai LifeSciences

Watchlist
  • 10.700
  • +0.170+1.61%
Close May 14 16:00 ET
  • 10.700
  • 0.0000.00%
Post 16:20 ET
1.42BMarket Cap-10819P/E (TTM)

Maravai LifeSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-109.95%-8.47M
-76.45%126.22M
-92.16%7.79M
-87.13%14.17M
-88.32%19.19M
-47.58%85.07M
45.42%535.98M
69.10%99.34M
4.26%110.06M
-1.00%164.28M
Net income from continuing operations
-1,582.49%-22.68M
-128.20%-138.38M
-225.80%-109.98M
-115.15%-15.1M
-107.62%-11.94M
-100.92%-1.35M
4.56%490.66M
-31.22%87.43M
-24.61%99.65M
16.52%156.72M
Operating gains losses
-318.56%-1.92M
----
----
----
----
322.12%878K
101.85%208K
--0
--0
--0
Depreciation and amortization
26.09%13.75M
28.02%48.78M
29.42%12.98M
32.16%13.1M
32.43%11.8M
17.84%10.91M
13.59%38.1M
10.45%10.03M
23.83%9.91M
-12.36%8.91M
Deferred tax
--0
1,683.97%754.94M
10,807.86%764.75M
-159.91%-5.53M
-121.44%-2.76M
-111.50%-1.52M
-9.78%42.32M
-59.86%7.01M
-17.75%9.23M
99.29%12.86M
Other non cash items
-47.35%963K
-7,443.03%-671.56M
-14,600.84%-671.68M
189.30%3.15M
34.33%-4.85M
169.65%1.83M
-140.23%-8.9M
42.35%4.63M
-53.66%-3.52M
-387.91%-7.39M
Change In working capital
-115.57%-10.64M
317.04%97.84M
115.09%2.38M
186.11%8.57M
266.71%18.55M
929.58%68.34M
74.48%-45.08M
84.30%-15.76M
72.25%-9.96M
-179.73%-11.13M
-Change in receivables
-78.30%17.88M
478.93%84.4M
65.92%-8.79M
-44.94%3.21M
6,674.78%7.56M
3,817.05%82.41M
68.36%-22.27M
49.99%-25.77M
-66.89%5.83M
-100.33%-115K
-Change in inventory
124.24%820K
-93.14%649K
-111.33%-2.18M
35.34%-1.5M
188.60%7.71M
-381.68%-3.38M
143.84%9.46M
251.89%19.27M
72.98%-2.31M
-85.72%-8.7M
-Change in prepaid assets
103.17%730K
115.39%8.14M
138.64%6.38M
113.22%3.48M
269.42%21.29M
-1,014.26%-23.01M
-455.80%-52.87M
-374.63%-16.5M
-2,622.13%-26.32M
-180.00%-12.57M
-Change in payables and accrued expense
-215.87%-27.8M
194.47%20.39M
185.97%7.81M
-61.93%4.37M
-337.16%-15.77M
1,235.89%23.99M
349.01%6.93M
-237.50%-9.08M
1,245.55%11.47M
1,323.77%6.65M
-Change in other current liabilities
89.38%-1.13M
-176.81%-15.98M
-108.61%-1.64M
-209.38%-1.08M
-241.92%-2.65M
-856.09%-10.6M
560.12%20.8M
2,090.80%19.05M
624.34%991K
193.78%1.87M
-Change in other working capital
-8.70%-1.15M
103.51%250K
129.54%808K
-75.77%94K
-76.69%406K
83.77%-1.06M
89.50%-7.12M
95.16%-2.74M
100.91%388K
117.99%1.74M
Cash from discontinued investing activities
Operating cash flow
-109.95%-8.47M
-76.45%126.22M
-92.16%7.79M
-87.13%14.17M
-88.32%19.19M
-47.58%85.07M
45.42%535.98M
69.10%99.34M
4.26%110.06M
-1.00%164.28M
Investing cash flow
Cash flow from continuing investing activities
93.91%-4.24M
54.30%-122.31M
30.33%-12.9M
-165.44%-15.52M
-1,354.36%-24.16M
71.14%-69.73M
-353.29%-267.61M
-227.44%-18.52M
-104.93%-5.85M
63.36%-1.66M
Net PPE purchase and sale
-2,752.50%-4.24M
-229.61%-52.69M
-152.55%-12.9M
-139.99%-15.52M
-1,370.50%-24.43M
105.82%160K
-11.77%-15.99M
9.67%-5.11M
-386.61%-6.47M
63.36%-1.66M
Net business purchase and sale
--0
70.79%-69.62M
--0
--0
--109K
70.80%-69.73M
-298.70%-238.35M
---133K
-99.48%620K
--0
Net other investing changes
----
----
----
----
----
---159K
---13.28M
----
----
----
Cash from discontinued investing activities
Investing cash flow
93.91%-4.24M
54.30%-122.31M
30.33%-12.9M
-165.44%-15.52M
-1,354.36%-24.16M
71.14%-69.73M
-353.29%-267.61M
-227.44%-18.52M
-104.93%-5.85M
63.36%-1.66M
Financing cash flow
Cash flow from continuing financing activities
97.08%-560K
67.42%-61.09M
100.71%470K
102.09%783K
0.64%-43.13M
52.60%-19.21M
-17.89%-187.5M
-33.37%-66.12M
26.99%-37.44M
-27.20%-43.41M
Net issuance payments of debt
-10.66%-1.51M
-6.10%-5.77M
-10.44%-1.5M
-9.12%-1.48M
-4.85%-1.43M
0.00%-1.36M
9.33%-5.44M
9.33%-1.36M
9.33%-1.36M
9.33%-1.36M
Proceeds from stock option exercised by employees
----
-100.85%-20K
-196.16%-351K
-57.26%312K
----
----
37.98%2.36M
-3.95%365K
134.73%730K
19.87%537K
Net other financing activities
105.29%945K
70.01%-55.3M
103.57%2.32M
105.31%1.96M
2.02%-41.73M
55.25%-17.85M
-19.16%-184.42M
-34.40%-65.13M
26.52%-36.81M
-28.76%-42.59M
Cash from discontinued financing activities
Financing cash flow
97.08%-560K
67.42%-61.09M
100.71%470K
102.09%783K
0.64%-43.13M
52.60%-19.21M
-17.89%-187.5M
-33.37%-66.12M
26.99%-37.44M
-27.20%-43.41M
Net cash flow
Beginning cash position
-9.04%574.96M
14.67%632.14M
-6.13%579.61M
5.36%580.18M
45.61%628.27M
14.67%632.14M
133.41%551.27M
12.69%617.45M
46.96%550.68M
74.21%431.47M
Current changes in cash
-243.36%-13.27M
-170.70%-57.18M
-131.60%-4.64M
-100.86%-571K
-140.35%-48.1M
96.77%-3.87M
-74.34%80.87M
318.93%14.69M
-61.38%66.77M
-6.34%119.21M
Effect of exchange rate changes
----
--0
----
----
----
----
--0
----
----
----
End cash Position
-10.60%561.69M
-9.04%574.96M
-9.04%574.96M
-6.13%579.61M
5.36%580.18M
45.61%628.27M
14.67%632.14M
14.67%632.14M
12.69%617.45M
46.96%550.68M
Free cash flow
-118.30%-14.13M
-88.31%60.67M
-109.67%-9.01M
-101.60%-1.66M
-103.61%-5.87M
-51.61%77.21M
46.69%518.89M
75.41%93.12M
-0.61%103.59M
0.75%162.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -109.95%-8.47M-76.45%126.22M-92.16%7.79M-87.13%14.17M-88.32%19.19M-47.58%85.07M45.42%535.98M69.10%99.34M4.26%110.06M-1.00%164.28M
Net income from continuing operations -1,582.49%-22.68M-128.20%-138.38M-225.80%-109.98M-115.15%-15.1M-107.62%-11.94M-100.92%-1.35M4.56%490.66M-31.22%87.43M-24.61%99.65M16.52%156.72M
Operating gains losses -318.56%-1.92M----------------322.12%878K101.85%208K--0--0--0
Depreciation and amortization 26.09%13.75M28.02%48.78M29.42%12.98M32.16%13.1M32.43%11.8M17.84%10.91M13.59%38.1M10.45%10.03M23.83%9.91M-12.36%8.91M
Deferred tax --01,683.97%754.94M10,807.86%764.75M-159.91%-5.53M-121.44%-2.76M-111.50%-1.52M-9.78%42.32M-59.86%7.01M-17.75%9.23M99.29%12.86M
Other non cash items -47.35%963K-7,443.03%-671.56M-14,600.84%-671.68M189.30%3.15M34.33%-4.85M169.65%1.83M-140.23%-8.9M42.35%4.63M-53.66%-3.52M-387.91%-7.39M
Change In working capital -115.57%-10.64M317.04%97.84M115.09%2.38M186.11%8.57M266.71%18.55M929.58%68.34M74.48%-45.08M84.30%-15.76M72.25%-9.96M-179.73%-11.13M
-Change in receivables -78.30%17.88M478.93%84.4M65.92%-8.79M-44.94%3.21M6,674.78%7.56M3,817.05%82.41M68.36%-22.27M49.99%-25.77M-66.89%5.83M-100.33%-115K
-Change in inventory 124.24%820K-93.14%649K-111.33%-2.18M35.34%-1.5M188.60%7.71M-381.68%-3.38M143.84%9.46M251.89%19.27M72.98%-2.31M-85.72%-8.7M
-Change in prepaid assets 103.17%730K115.39%8.14M138.64%6.38M113.22%3.48M269.42%21.29M-1,014.26%-23.01M-455.80%-52.87M-374.63%-16.5M-2,622.13%-26.32M-180.00%-12.57M
-Change in payables and accrued expense -215.87%-27.8M194.47%20.39M185.97%7.81M-61.93%4.37M-337.16%-15.77M1,235.89%23.99M349.01%6.93M-237.50%-9.08M1,245.55%11.47M1,323.77%6.65M
-Change in other current liabilities 89.38%-1.13M-176.81%-15.98M-108.61%-1.64M-209.38%-1.08M-241.92%-2.65M-856.09%-10.6M560.12%20.8M2,090.80%19.05M624.34%991K193.78%1.87M
-Change in other working capital -8.70%-1.15M103.51%250K129.54%808K-75.77%94K-76.69%406K83.77%-1.06M89.50%-7.12M95.16%-2.74M100.91%388K117.99%1.74M
Cash from discontinued investing activities
Operating cash flow -109.95%-8.47M-76.45%126.22M-92.16%7.79M-87.13%14.17M-88.32%19.19M-47.58%85.07M45.42%535.98M69.10%99.34M4.26%110.06M-1.00%164.28M
Investing cash flow
Cash flow from continuing investing activities 93.91%-4.24M54.30%-122.31M30.33%-12.9M-165.44%-15.52M-1,354.36%-24.16M71.14%-69.73M-353.29%-267.61M-227.44%-18.52M-104.93%-5.85M63.36%-1.66M
Net PPE purchase and sale -2,752.50%-4.24M-229.61%-52.69M-152.55%-12.9M-139.99%-15.52M-1,370.50%-24.43M105.82%160K-11.77%-15.99M9.67%-5.11M-386.61%-6.47M63.36%-1.66M
Net business purchase and sale --070.79%-69.62M--0--0--109K70.80%-69.73M-298.70%-238.35M---133K-99.48%620K--0
Net other investing changes -----------------------159K---13.28M------------
Cash from discontinued investing activities
Investing cash flow 93.91%-4.24M54.30%-122.31M30.33%-12.9M-165.44%-15.52M-1,354.36%-24.16M71.14%-69.73M-353.29%-267.61M-227.44%-18.52M-104.93%-5.85M63.36%-1.66M
Financing cash flow
Cash flow from continuing financing activities 97.08%-560K67.42%-61.09M100.71%470K102.09%783K0.64%-43.13M52.60%-19.21M-17.89%-187.5M-33.37%-66.12M26.99%-37.44M-27.20%-43.41M
Net issuance payments of debt -10.66%-1.51M-6.10%-5.77M-10.44%-1.5M-9.12%-1.48M-4.85%-1.43M0.00%-1.36M9.33%-5.44M9.33%-1.36M9.33%-1.36M9.33%-1.36M
Proceeds from stock option exercised by employees -----100.85%-20K-196.16%-351K-57.26%312K--------37.98%2.36M-3.95%365K134.73%730K19.87%537K
Net other financing activities 105.29%945K70.01%-55.3M103.57%2.32M105.31%1.96M2.02%-41.73M55.25%-17.85M-19.16%-184.42M-34.40%-65.13M26.52%-36.81M-28.76%-42.59M
Cash from discontinued financing activities
Financing cash flow 97.08%-560K67.42%-61.09M100.71%470K102.09%783K0.64%-43.13M52.60%-19.21M-17.89%-187.5M-33.37%-66.12M26.99%-37.44M-27.20%-43.41M
Net cash flow
Beginning cash position -9.04%574.96M14.67%632.14M-6.13%579.61M5.36%580.18M45.61%628.27M14.67%632.14M133.41%551.27M12.69%617.45M46.96%550.68M74.21%431.47M
Current changes in cash -243.36%-13.27M-170.70%-57.18M-131.60%-4.64M-100.86%-571K-140.35%-48.1M96.77%-3.87M-74.34%80.87M318.93%14.69M-61.38%66.77M-6.34%119.21M
Effect of exchange rate changes ------0------------------0------------
End cash Position -10.60%561.69M-9.04%574.96M-9.04%574.96M-6.13%579.61M5.36%580.18M45.61%628.27M14.67%632.14M14.67%632.14M12.69%617.45M46.96%550.68M
Free cash flow -118.30%-14.13M-88.31%60.67M-109.67%-9.01M-101.60%-1.66M-103.61%-5.87M-51.61%77.21M46.69%518.89M75.41%93.12M-0.61%103.59M0.75%162.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg